Estrella Clinical Research SRL
Estrella Clinical Research reported total assets of 41,482 € at the end of the 2025 financial year (annual accounts filed with the NBB on 18 Jun 2026).
The score of Estrella Clinical Research shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -80 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Estrella Clinical Research's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 Jun 2026
- Year ended 31 Dec 2024filed on 18 Jun 2025
- Year ended 31 Dec 2023filed on 25 Jun 2024
- Year ended 31 Dec 2022filed on 27 Jun 2023
- Year ended 31 Dec 2021filed on 13 Jun 2022
Estrella Clinical Research's financial analysis
- Solvency-19.6%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Estrella Clinical Research
Estrella Clinical Research's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0737.730.926
- VAT number
- BE0737730926
- Peppol
- Registered · 0208:0737730926 · as of 12 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Nov 2019
- Registered office
- 2200 Herentals
- Latest accounts
- 2025 · filed on 18 Jun 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Estrella Clinical Research (SRL) has been based in Herentals since 2019, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net loss of 10,112 € and equity of −8,112 €; its revenue is not published. Its solvency stands at -19.6%, below the median of its sector (56.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Estrella Clinical Research
Companies in the same business, of comparable size and area, outside its group.
- MC Pharma Manufacture of basic pharmaceutical products Beaumont · balance sheet 28,699 €
- Matsen Life Sciences Diagnostic imaging services and medical laboratory activities Londerzeel · balance sheet 73,064 €
- Biomdrin Manufacture of pharmaceutical preparations Schilde · balance sheet 38,268 €
- RPO NucleoGenesis Manufacture of basic pharmaceutical products Ghent · balance sheet 107,514 €
- Inchinn Therapeutics Manufacture of basic pharmaceutical products Charleroi · balance sheet 51,394 €
- Arcom Diagnostic imaging services and medical laboratory activities Antwerp · balance sheet 141,138 €
- Evarmed Manufacture of basic pharmaceutical products Diepenbeek · balance sheet 51,346 €
- E.J.L. ExAct Manufacture of basic pharmaceutical products Ostend · balance sheet 59,234 €
Frequently asked questions about Estrella Clinical Research
What is the revenue of Estrella Clinical Research?
Estrella Clinical Research files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Estrella Clinical Research?
In Belgium, the VAT number is the company number prefixed with BE: BE0737730926 for Estrella Clinical Research, if the company is VAT-registered. Its company number (CBE) is 0737.730.926.
Where is the registered office of Estrella Clinical Research?
According to the CBE register, the registered office of Estrella Clinical Research is in 2200 Herentals.
What is the equity of Estrella Clinical Research?
At the close of the 2025 financial year, the equity of Estrella Clinical Research amounts to -8,112 €, a solvency of -19.6% of total assets.
Who manages Estrella Clinical Research?
The register lists 1 active mandates at Estrella Clinical Research. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Estrella Clinical Research
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →